Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical…
Jameson Connects & Crepdog Crew Celebrate Subcultures with Limited-Edition Capsule
Celebrating community, creativity, and self-expression through a limited-edition drop inspired by India's…